The pill (a hormone treatment)

The combined oral contraceptive pill ('the pill') may help some women if their acne seems to be partly related to their hormone changes. For example, acne that began or became worse in adulthood, or if acne seems to flare up around the time of a period. It is the oestrogen part of the pill that is thought to help. A variant of the combined pill called co-cyprindiol (trade name of Dianette) may be especially useful where a sensitivity to androgen hormone is thought to be making acne worse. For example, for women with excess facial hair growth in addition to acne. Co-cyprindiol contains a combination of an oestrogen plus cyproterone (an anti-androgen).

Isotretinoin tablets

Isotretinoin greatly reduces the amount of sebum that you make by the sebaceous glands. It works very well, and usually clears spots even in severe cases. However, it is normally used only on the advice of a specialist after other treatments have been tried first. This is because there is a risk of serious side-effects with isotretinoin tablets.

Whatever treatment is used, it is normal to take up to four weeks for there to be any noticeable improvement in the skin. There is often a good response to treatment by six weeks. However, it can take up to four months (sometimes longer) for maximum response to a treatment, and for the skin to be generally free of spots. The most common reason for a treatment failure is because some people think that treatment is not working after a couple of weeks or so, and give up.

Therefore, persevere with any treatment for at least six weeks before deciding if it is working or not. If there is no improvement after six weeks of taking a treatment regularly and correctly, do not despair. Adding in another treatment, or a change to a different or more powerful treatment will usually be advised, and is likely to work. Although treatment can usually clear most spots, no treatment will make your skin perfect, and the odd spot may remain.

• Back
• Next: Will acne return after treatment?

• Comment
• Send to a friend
• Print: Article |  Page